Presentation TCT 2013 The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity Presenter: David Maron October 29, 2013
Presentation TCT 2013 Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR? Presenter: Larry Wood October 29, 2013
Presentation TCT 2013 Case Presentation 1: A Long-Run Restenosis Tale Presenter: Marin Postu October 29, 2013
Presentation TCT 2013 Stroke Prevention During Cardioversion: Are TEEs Needed? Presenter: Allan Klein October 29, 2013
Presentation TCT 2013 Correlates for Device Malposition during Aortic Valve-in-Valve Implantation: Insights from the Global Valve-in-Valve Registry Presenter: Danny Dvir October 29, 2013
Presentation TCT 2013 Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA Presenter: Miroslava Stolcova October 29, 2013
Presentation TCT 2013 TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV... Presenter: Thierry Lefevre October 29, 2013
Presentation TCT 2013 Pre-Treatment With High Dose Statin Decreases Cardiovascular Events In Unstable Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis Of Randomized Controlled Trials Presenter: Georges E. El-Hayek October 29, 2013
Presentation TCT 2013 Case Presentation and Topic Review: A Symptomatic HCM Patient Without Resting Obstruction Presenter: Morton Kern October 29, 2013